INC-101

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameINC-101
Drug Alias Namesubarachnoid hemorrhage therapy (Inncardio/Sigmoid Biotechnologies)INC-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIreland
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLong-E International
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLong-E International
Active IndicationsN/A
Inactive IndicationsStroke

Other Information

ATC CodeN/A
Related LinksN/A